Skip to content
Catalyst

glycineFinding

Glycine decreases PANSS negative subscale score

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Glycine administration resulted in (1) a significant (P<.001) 30%+/-16% reduction in negative symptoms, as measured by the PANSS, and (2) a significant (P<.001) 30%+/-18% improvement in the BPRS total scores.”
Quoted verbatim from Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
This finding among the 1 finding on its endpoint

glycine

PANSS negative subscale score

lowers

Who
Twenty-two treatment-resistant schizophrenic patients with enduring negative symptoms, glycine added to ongoing antipsychotic medication in a double-blind placebo-controlled crossover
Dose studied
0.8 g/kg per day glycine added to ongoing antipsychotic medication

Very limited evidencePMID 9892253 · 1999

02 · The study

Study
crossover
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7EQF13REF186W79J4SZXQVT